Advertisements


Why NewLink Genetics Shares Hit an All-Time Low

NewLink Genetics shares hit an all-time low in Monday’s session after the company provided an update on its brain tumor trial......»»

Category: blogSource: 247wallstApr 16th, 2018

NewLink Genetics shares plummet 39% after Merck, Incyte trial failure

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 6th, 2018

NewLink shares fall on late-stage trial changes

NewLink Genetics Corp. shares fell as much as 15% in premarket trade Monday after the company said it won't proceed as planned with a late-stage trial of its indoximod for advanced melanoma. The company will inst.....»»

Category: topSource: marketwatchApr 16th, 2018

NewLink Shares Plunge After Incyte & Merck"s Study Fails

Shares of NewLink Genetics Corp. (NLNT) plunged about 42.6% following the news of the failure of Incyte and Merck's phase III .....»»

Category: smallbizSource: nytApr 9th, 2018

NewLink Genetics plans to review clinical programs after Merck, Incyte trial failure

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 6th, 2018

NewLink Genetics calls being bought as shares suffer steep losses

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 6th, 2018

What Has Tanked Incyte and NewLink Genetics

Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage collaboration with Merck. NewLink Genetics felt the sting as well......»»

Category: blogSource: 247wallstApr 6th, 2018

Bank Of America Sees NewLink Genetics As "Undervalued"

Reasoning that NewLink Genetics Corp (NASDAQ: NLNK) shares are undervalued, Bank of America Merrill Lynch initiated coverage at Buy with a $22 price target. .....»»

Category: blogSource: benzingaOct 13th, 2017

Analyst: NewLink Shares Have Doubled This Month And There"s Still Room For More Upside

Investors and analysts don’t seem to be in lockstep when it comes to NewLink Genetics Corp (NASDAQ: NLNK)’s potential. La.....»»

Category: blogSource: benzingaSep 11th, 2017

NewLink Genetics Follows Through On Thursday"s Rally After Upgrade

NewLink Genetics Corp (NASDAQ: NLNK) shares are trading higher by $4.65, or 35 percent, at $18.25 in Friday's session. read more.....»»

Category: blogSource: benzingaSep 8th, 2017

Biogen to buy 11.5 mln Ionis shares at an 18.5% premium to Thursday"s closing price

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 20th, 2018

Atlassian shares fall 12.5% premarket

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 20th, 2018

Twitter shares up 2% in premarket trading

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 20th, 2018

Skechers shares fall 17% after earnings

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 19th, 2018

Gilead shares drop 2% on FDA concerns with similar Eli Lilly, Incyte drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 19th, 2018

GW Pharma shares have been halted since this morning

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 19th, 2018

Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 19th, 2018

U.S. stocks open slightly lower as technology, consumer-staples shares come under early pressure

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 19th, 2018

American Express shares up 2.5% after earnings

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 18th, 2018

IBM is getting rocked after giving disappointing guidance

IBM beat on both Wall Street estimates on both the top and bottom lines. Full year 2018 earnings guidance disappointed. Shares are down more than 7%. Watch IBM trade in real time here. IBM shares are getting rocked........»»

Category: topSource: moneycentralApr 18th, 2018

Novanta (NOVT) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Novanta Inc. (NOVT). As of late, it has definitely been a great time to be an investor.....»»

Category: worldSource: nytApr 18th, 2018